New approaches to regulating the chondroitin/dermatan sulfate glycosaminoglycan component of the vascular extracellular matrix.
Nigro
Julie
J
Cell Biology of Diabetes Laboratory, Baker Heart Research Institute, Melbourne, Victoria, Australia. julie.nigro@baker.edu.au
Ballinger
Mandy L
ML
Survase
Soniya
S
Osman
Narin
N
Little
Peter J
PJ
D000818:Animals; D050197:Atherosclerosis / Q000378:metabolism*; D002809:Chondroitin Sulfates / Q000378:metabolism*; D003871:Dermatan Sulfate / Q000031:analogs & derivatives / Q000378:metabolism*; D005109:Extracellular Matrix / Q000378:metabolism*; D006025:Glycosaminoglycans / Q000378:metabolism*; D006801:Humans; D008955:Models, Cardiovascular; D009131:Muscle, Smooth, Vascular / Q000378:metabolism*; D032389:Myocytes, Smooth Muscle / Q000378:metabolism; D011509:Proteoglycans / Q000378:metabolism*
D006025:Glycosaminoglycans; D011509:Proteoglycans; C069524:dermatan sulfate chondroitin sulfate; D003871:Dermatan Sulfate; D002809:Chondroitin Sulfates